The field of urologic oncology has witnessed rapid progress in recent years, fueled by breakthroughs in diagnosis, treatment, and patient care. Innovative therapeutic strategies such as targeted therapy and immunotherapy are transforming the landscape of urologic cancer management. Additionally, advancements in imaging techniques facilitate earlier